Documenti fondamentali

Visualizza tutta la documentazione

Vai a

1287008

USP

Furosemide

Name: Furosemide
Brand: USP
Price: 511 CHF

United States Pharmacopeia (USP) Reference Standard

Sinonimo/i:

4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid, 5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Taglio della confezione	SKU	Disponibilità	Prezzo
200 mg		Per conoscere la disponibilità, visualizza il carrello	CHF 511.00

Informazioni su questo articolo

Formula empirica (notazione di Hill):

C₁₂H₁₁ClN₂O₅S

Numero CAS:

54-31-9

Peso molecolare:

330.74

NACRES:

NA.24

PubChem Substance ID:

329749916

UNSPSC Code:

41116107

MDL number:

MFCD00010549

CHF 511.00

Per conoscere la disponibilità, visualizza il carrello

Richiedi un ordine in blocco

Servizio Tecnico

Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.

Permettici di aiutarti

Proprietà

grade

pharmaceutical primary standard

agency

USP

API family

furosemide

manufacturer/tradename

USP

mp

220 °C (dec.) (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl

InChI

1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)

InChI key

ZZUFCTLCJUWOSV-UHFFFAOYSA-N

Gene Information

human ... SLC12A1(6557)

Descrizione

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Furosemide USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Furosemide Injection
Furosemide Oral Solution
Furosemide Tablets

Biochem/physiol Actions

Inhibits ion co-transport in the kidney.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo	BP547	Y0001493	F0700000
USP 1287008 Furosemide	BP547 Furosemide	Y0001493 Furosemide for peak identification	F0700000 Furosemide
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard
manufacturer/tradename USP	manufacturer/tradename BP	manufacturer/tradename EDQM	manufacturer/tradename EDQM
format neat	format neat	format neat	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)
API family furosemide	API family furosemide	API family furosemide	API family furosemide
mp 220 °C (dec.) (lit.)	mp 220 °C (dec.) (lit.)	mp 220 °C (dec.) (lit.)	mp 220 °C (dec.) (lit.)

Still not finding the right product?

Explore all of our products under Furosemide

pictograms

GHS08,GHS07

signalword

Danger

hcodes

H302,H360FD

pcodes

P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405

Hazard Classifications

Acute Tox. 4 Oral - Repr. 1B

Classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

flash_point_f

Not applicable

flash_point_c

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.

Adam D DeVore et al.

European journal of heart failure, 17(3), 340-346 (2015-01-27)

Loop diuretics are a cornerstone of heart failure (HF) treatment, but data regarding diuretic dose adjustments after a HF hospitalization and the association with subsequent outcomes are limited. This study was therefore conducted to determine these factors. We analysed data

Narrative review: furosemide for hypercalcemia: an unproven yet common practice.

Susan B LeGrand et al.

Annals of internal medicine, 149(4), 259-263 (2008-08-20)

Although primary hyperparathyroidism is the most common cause of hypercalcemia, cancer is the most common cause requiring inpatient intervention. An estimated 10% to 20% of all patients with cancer have hypercalcemia at some point in their disease trajectory, particularly in

The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide.

Daryl W Hochman

Epilepsia, 53 Suppl 1, 18-25 (2012-05-25)

Treatments that modulate the size of the extracellular space (ECS) also block epileptiform activity in adult brain tissue. This includes the loop diuretics furosemide and bumetanide, and alterations of the osmolarity of the ECS. These treatments block epileptiform activity in

Visualizza tutti i documenti correlati

Numero articolo commerciale globale

SKU	GTIN
1287008-200MG	04061838725875

Questions

Reviews

No rating value